← Insider Monitor

IMVT
Immunovant, Inc.
Recent activity from public SEC and congressional filings.
5
Insider trades
0
Congress trades
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Stout Jay SChief Technology Officer | Sell | $71K | 2,213at $32.06 | Oct 7, 2026 |
| Stout Jay SChief Technology Officer | Sell | $51K | 1,596at $32.06 | Oct 7, 2026 |
| Gloria MelanieChief Operating Officer | Sell | $72K | 2,241at $32.06 | Oct 7, 2026 |
| Van Tuyl ChristopherChief Legal Officer | Sell | $43K | 1,327at $32.06 | Oct 7, 2026 |
| Venker EricChief Executive Officer | Sell | $120K | 3,506at $34.11 | Oct 2, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
No recent congressional disclosures found for IMVT.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable IMVT activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.